Mark Ragosa, CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 36,722 shares at $45.58 ($1.7M) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Open-market sale of $1.7M KNSA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.58 | 17,981 | $820K | 48.6% |
| 2 | $46.24 | 18,741 | $867K | 51.4% |
| Total | $45.92 avg | 36,722 | $1.7M | 100% |
| Filing → |
| KNSA | SELL | 2025-12-10 | $3.6M | — | Filing → |
| KNSA | SELL | 2025-11-14 | $815K | — | Filing → |
| KNSA | SELL | 2025-10-30 | $4K | — | Filing → |